2024-04-26

Nicola Longo, who with his wife, Marzia Pasquali, is credited with expanding screening for a treatable metabolic disorder, is leaving for UCLA while Pasquali stays at ARUP to continue key projects.

2024-04-24

A new partnership between ARUP and connectivity provider ELLKAY aims to give health systems the testing support, guidance, and technology needed to establish or expand lab outreach operations.

2024-04-18

The ARUP Consult Laboratory Testing for Developmental Delay, Intellectual Disability, and Autism Spectrum Disorder topic now includes exome and genome sequencing as a first- or second-tier test.

2024-03-21

The FDA’s proposed rule to regulate lab-developed tests will force labs to halt essential testing, harming children and patients with cancer and rare diseases, says ARUP’s Jonathan Genzen, MD, PhD.

2024-03-15

Of the ARUP clients who participated in the 2023 client satisfaction survey, 93% had a favorable impression of the company, up from 91% in 2022.

2024-03-08

ARUP’s returnships are short-term, paid opportunities designed for skilled professionals with an employment gap of one year or longer for any reason including military service or family obligation.

2024-03-05

Nearly 85% of respondents to an ARUP survey believe the FDA’s proposed rule to regulate lab-developed tests will negatively impact their labs. Only 3% believe they have the financial resources to comply.

2024-03-01

ARUP is committed to continue offering quality, esoteric testing that can aid patients with rare diseases on their often difficult diagnostic journeys.

2024-02-29

February is American Heart Month, and ARUP Consult has current resources on testing for acute coronary syndrome, heart failure, and atherosclerotic cardiovascular disease markers.

2024-02-05

Researchers at ARUP Laboratories published more than 130 peer-reviewed articles and contributed more than 135 posters or presentations at medical conferences in FY2023 to advance laboratory medicine.

Subscribe to Corporate News